Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has received three grants totaling more than CHF 1.3 ...

TOKYO, Sept 24, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment ...

The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III ...

BILLINGS — Hundreds gathered at ZooMontana for the first-ever ALS walk in Billings, hoping to raise funds for research and awareness. ALS stands for amyotrophic lateral sclerosis and is a nervous ...

The Oak Ridge Boys share Joe Bonsall's struggle with ALS, talk moving on, and new music in an exclusive interview with American Songwriter.

When comparing Clover Health Medicare Advantage to two other randomly chosen Medicare Advantage plans offered by large health ...

A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...

On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and ...

A UNIGE team has discovered the genetic programs that allow motor neurons to retract from the spinal cord. This discovery ...

Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s ...

Shares of Cosciens Biopharma fell Monday morning after it said it will discontinue research into its ALS treatment as management continues to lay off staff and cut costs across the company. Shares ...

Tim Boreham is back in the studio for another instalment of Health Kick, this time chatting to PharmAust (ASX:PAA) MD, ...